The FDA may give drug manufacturer Purdue Pharma a six-month extension of its original OxyContin patent as an incentive for the completed pediatric study.
Related Articles on Pain Management:
Study: Hospitals Struggle With Pediatric Pain
Pain Management Physician Joins Coastal Orthopedics
Report: Florida Closed Half of Pain Management Clinics in Two Years
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
